Educational information only. Realvigor does not diagnose or replace medical care.
5-alpha-reductase inhibitor

Finasteride (Proscar) for BPH

A treatment-decision hub connecting mechanism, common research questions, comparisons and side-effect topics.

Direct answer: Finasteride is a 5-alpha-reductase inhibitor used in BPH treatment. It reduces conversion of testosterone to DHT, which can reduce prostate volume over time. Whether it is appropriate depends on symptoms, prostate characteristics, other conditions, concurrent medications and patient preferences.

What Finasteride does

Finasteride belongs to the 5-alpha-reductase inhibitor class. This hub is intentionally decision-focused rather than encyclopedic: it links to questions people commonly research when choosing, evaluating or reconsidering treatment.

Questions people usually compare

What is actually different about this class?

Alpha blockers primarily change smooth-muscle tone and tend to have a faster symptom-focused role. 5-alpha-reductase inhibitors change DHT signaling and prostate volume over a longer time horizon. PDE5 inhibition represents another mechanism and can be relevant when urinary symptoms and erectile function overlap. These distinctions are why Realvigor creates separate comparison pages rather than collapsing all BPH medication queries into one generic article.

Questions to discuss with a clinician

  • What treatment goal matters most in my case: faster symptom relief, prostate-size reduction, sexual-function considerations, or progression risk?
  • How long should this medication be tried before judging response?
  • Which side effects should prompt a call or follow-up?
  • Does this medication affect blood pressure, PSA interpretation or other medications I take?
  • When would combination therapy or a procedure be considered?
Educational information only. Do not start, stop or change Finasteride based on this page.
Written by: Realvigor Editorial Team · Medical reviewer: not yet assigned · Status: Phase 1–5 foundation page
Phase 7 decision cluster

Finasteride treatment decision center

Use these focused guides to compare finasteride, understand PSA changes, investigate side effects and research what to discuss when treatment is not meeting your goals.

Finasteride vs Dutasteride for BPH

Compare finasteride and dutasteride for BPH by 5-alpha-reductase activity, prostate shrinkage, PSA effects, side effects and treatment decisions.

Finasteride vs Tadalafil for BPH

Compare finasteride with tadalafil for BPH, including prostate shrinkage, urinary symptoms, erectile dysfunction, PSA effects and treatment trade-offs.

Proscar vs Flomax for BPH

Compare Proscar (finasteride) and Flomax (tamsulosin) for BPH by speed, prostate shrinkage, PSA effects and sexual or blood-pressure trade-offs.

Finasteride and Erectile Dysfunction

Can finasteride cause erectile dysfunction? Review BPH prescribing data, other possible causes, timing and questions to discuss with your clinician.

Finasteride Sexual Side Effects

Review finasteride sexual side effects for BPH, including erectile dysfunction, decreased libido, ejaculate-volume changes and treatment decisions.

Finasteride and Low Libido

Low sex drive while taking finasteride? Review what the prescribing information supports, other contributors and how to prepare for a medication review.

Finasteride and Ejaculation Changes

Review ejaculation changes reported with finasteride, including reduced ejaculate volume and ejaculation disorder, plus questions to discuss with a clinician.

Finasteride Long-Term Side Effects for BPH

Review long-term finasteride side-effect considerations for BPH, including sexual symptoms, breast changes, PSA interpretation and ongoing monitoring.

Finasteride and PSA

Finasteride can substantially lower PSA. Learn why that matters, what a rising PSA can mean and why clinicians need to know you take finasteride.

Interpreting PSA While Taking Finasteride

How should PSA be interpreted while taking finasteride? Review the roughly 50% lowering effect, nadir trends and why confirmed rises deserve evaluation.

PSA After Stopping Finasteride

PSA after stopping finasteride can be difficult to interpret without the treatment timeline. Learn what information to bring to your clinician.

Rising PSA While Taking Finasteride

A confirmed PSA rise while taking finasteride deserves evaluation. Learn why nadir trends matter and what information clinicians use.

How Long Does Finasteride Take to Work for BPH?

Finasteride is slower than alpha blockers because it changes DHT and prostate growth. Learn what “working” means and when reassessment becomes useful.

Finasteride Prostate Shrinkage Timeline

Understand the finasteride prostate-shrinkage timeline, why benefit is gradual and which outcomes clinicians may track beyond day-to-day urinary symptoms.

Stopping Finasteride for BPH

Thinking about stopping finasteride for BPH? Review why it was prescribed, PSA implications, symptom recurrence and alternatives before changing treatment.

Finasteride Not Working for BPH

If finasteride seems not to be working, review treatment duration, prostate size, symptom type, adherence, combination therapy and procedure options.

Finasteride Alternatives for BPH

Compare finasteride alternatives for BPH, including dutasteride, alpha blockers, tadalafil, combination therapy and procedure pathways.

Finasteride Alternatives When Sexual Side Effects Matter

Concerned about sexual side effects on finasteride? Compare what changes and what new trade-offs appear with other BPH medication classes and procedures.

Finasteride vs UroLift for BPH

Compare finasteride with UroLift for BPH by prostate-size strategy, daily medication, recovery, durability and sexual-function trade-offs.

Finasteride vs Rezūm for BPH

Compare finasteride with Rezūm for BPH by prostate-size strategy, daily medication, recovery, durability and sexual-function trade-offs.